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Abstract. Breast cancer (BC) is the most prevalent type of cancer among women 
and one of the major causes of cancer mortality in women. Metastasis in breast 
cancer (BC) occurs due to immunosurveillance deficiency, including impairment 
of natural killer (NK) cell maturation. Conditioned medium (CM) from human 
Wharton’s jelly mesenchymal stem cells (hWJMSC-CM) is known to possess 
anticancer activity. The CM of co-culture of human recombinant IL-2 treated 
NK cells and hWJMSCs is expected to boost anticancer activity toward BC cells 
which can be analyzed from the effect of CM towards secretion of effector 
molecules and expression of BC cell apoptosis-related genes, and cytotoxic 
granules in human recombinant IL-2 treated NK (IL-2 NK) and hWJMSCs (IL-2 
hWJMSCs). TNF-α, IFN-γ, perforin, granzyme were measured by ELISA, while 
the inhibition of cell proliferation was measured by MTS assay and BC cell 
apoptosis by flow cytometry and apoptotic gene expression by RTPCR. CM 
from co-cultured hWJMSCs and IL-2 NK cells inhibited NK and BC cell 
proliferation, increased expression of Bax and p53 and decreased the number of 
Bcl-2 in BC cells. In conclusion, CM of co-culture IL-2 treated NK cells and 
hWJMSCs induce apoptosis in BC cells as indicated by increased Bax and p53 
expression and decreased Bcl-2 expression. 
Keywords: breast cancer; conditioned medium; human Wharton’s jelly mesenchymal 
stem cells; interleukin-2; natural killer cells.  
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1 Introduction 
Breast cancer (BC) is one of the most regularly recognized cancer types and is 
the first cause of female cancer mortality [1]. Metastatis to organs is the main 
cause of patient mortality [1]. An ideal therapeutic strategy is therefore needed 
to target metastatic and non-metastatic tumor cells directly, which has to show 
local activity over the time of treatment [2]. Metastatic tumor cells require 
invasive and escaping ability in response to immune cells to be able to spread to 
other organs [3-5]. BC occurrence and its metastatis may also be supported by 
antitumor immunity [6], immunosurveillance deficiency, natural killer (NK) cell 
maturation damage, a low number of NK cells and decreased cytotoxic activity 
in peripheral blood mononuclear cells (PBMCs) [7-10], NK abnormalities [11], 
low tumor infiltration [12,13], abnormal expression of activating receptors, and 
overexpression of inhibitory receptors CD158a, CD158b, and NKG2A [10]. 
Stimulating NK cell functions in combination with other anticancer agents to 
improve their anticancer activity is a promising cancer therapy [14]. Interleukin-
2 (IL-2) can be used to trigger NK cells [15]. Cytoplasmic granules, perforin 
(Prf1) and granzymes (Gzm) are released by NK cells to suppress cancer, 
leading to apoptosis [16]. Secretomes such as TNF-α and several effector 
molecules such as IFN-γ can lead to apoptosis of cancer cells [17]. Another 
promising anticancer agent is the secretome of mesenchymal stem cells (MSCs) 
found in conditioned medium (CM), which contains microparticles that mediate 
therapeutic effects against cancer [18]. MSCs release various factors that can 
inhibit proliferation of glioma, melanoma, lung cancer, hepatoma, and breast 
cancer cells [19-22]. Furthermore, MSCs-CM inhibits mammary carcinoma, 
osteosarcoma, pancreatic, and lung tumor growth [23].  
To date, hWJMSC-CM is known to exhibit anticancer activities, yet further 
development to enhance its potential is still required. An approach suggesting 
the increase of cytokines such as IL-2 as anticancer treatment may directly 
induce NK cells to target cancer cells and hWJMSC-CM indirectly. In this 
research, we aimed to elucidate the properties of IL-2 hWJMSC-CM against BC 
and NK cell viability, the effect of IL-2 NK cells on BC cell inhibition, NK cell 
proliferation, and the levels of TNF-α, IFN-γ, perforin, and granzyme, and 
cytotoxic activity of IL-2 NK against BC cells. 
2 Materials and Methods 
2.1 Interleukin 2-induced Human Wharton’s Jelly Mesenchymal 
Stem Cells (IL-2 hWJMSCs) 
Human Wharton’s jelly mesenchymal stem cells (hWJMSCs) at passage 4 (P4) 
were obtained from our previous study [23]. Surface marker expression and 
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differentiation ability into three different lineages was performed in order to 
characterize the hWJMSCs [23,24]. The informed consent from all donors and 
protocol approval of the Institutional Ethics Committee at the Stem Cell and 
Cancer Institute, Jakarta, Indonesia and the Institutional Ethics Committee 
collaboration between Maranatha Christian University, Bandung, Indonesia and 
Immanuel Hospital Bandung, Bandung, Indonesia were obtained to conduct this 
research. 5 × 105 hWJMSCs were maintained in minimum essential medium-α 
(MEM-α) (Gibco, 12561056), supplemented with 20% fetal bovine serum (FBS, 
Gibco 10270106) and 1% of Antibiotic-Antimycotic (Gibco, 1772653) and 
incubated in 5% CO2 at 37 °C for 24 h. Then, the medium was replaced and the 
cells were washed with 1 x PBS sterile and supplemented with new growth 
medium. Next, the cells were treated with 125 and 250 ng/ml of IL-2 
(Biolegend, 589106) and incubated in 5% CO2, at 37 °C for 24 h. The IL-2 
hWJMSCs were harvested and the medium supernatant was collected, 
centrifuged at 500 g for four mins at room temperature and filtered through a 
0.22 μm Millexe-GV Filter Unit with Durapore (Millipore, SLGV 033 RS). The 
filtered medium, i.e. conditioned medium of IL-2 hWJMSCs, was stored 
at -80 °C [23-25]. 
3 Cytotoxic Activity of IL-2 hWJMSC-CM toward Breast 
Cancer Cells 
The breast cancer cell lines, i.e. MCF-7 (ATCC® HTB22™), were obtained 
from the Aretha Medika Utama, Biomolecular and Biomedical Research Center, 
Bandung, Indonesia. Around 5 × 103 cells/well of MCF-7 were maintained in 
Dulbecco’s Modified Eagle’s Medium (DMEM; Gibco, 11995065) 
supplemented with 10% FBS and 1% Antibiotic-Antimycotic. Then, the cells 
were incubated at 5% CO2, 37 °C for 24 h [23,26,27]. Moreover, various 
concentrations of IL-2 hWJMSC-CM (30% and 60%) were used to treat the 
cultured MCF-7, which was incubated for around 24 h. The viability of the cells 
was counted based on an optimized reagent containing resazurin, which was 
converted to fluorescent resorufin by viable cells absorbing light at 490 nm in a 
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetra-zolium (MTS) assay (Promega, Madison, WI, USA). The absorbance 
of the cells was measured at 490 nm using a spectrophotometer (Multiskan Go, 
Thermo Scientific) [23-26]. 
3.1 Cytotoxic Activity of IL-2 hWJMSC-CM toward NK Cells 
NK92MI cell line (ATCC® CRL2408™) was obtained from Aretha Medika 
Utama, Biomolecular and Biomedical Research Center, Bandung, Indonesia. 
1 × 104 cells/well of NK92MI were plated in a 96-well plate and maintained in 
RPMI 1640 medium (Gibco, 22400089) supplemented with 10% FBS, 1% 
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Antibiotic-Antimycotic. Next, the cells were treated with various concentrations 
of IL-2 hWJMSC-CM (30% and 60%) and then incubated for 24 h. Cell 
viability in each well was measured by MTS assay, as described in Section 2.2. 
[23,26]. 
3.2 Cytoplasmic Granule and Effector Molecule Measurement of 
hWJMSCs and IL-2 NK Cells in Co-Culture Conditon 
NK92MI cells were grown at density 2 × 106 cells/well in NK medium 
containing RPMI 1640, 20% FBS, 1% Antibiotic-Antimycotic. Then, the cells 
were treated with 10 ng/ml of human recombinant IL-2 and incubated at 5% 
CO2, 37 °C for 96 h, which resulted in IL-2 induced NK (IL-2 NK) cells. The 
hWJMSCs were cultured at a density of 1 × 106 cells/well in MEM-α, 
supplemented with 10% FBS, 1% Antibiotic-Antimycotic and incubated in 5% 
CO2, 37 °C for 24 h. Furthermore, NK cells at density 5 × 106 cells/well were 
plated in a 24-well plate to achieve a ratio of 1:5 (hWJMSCs : NK = 1:5; 
hWJMSCs : IL-2 NK = 1:5), containing hWJMSCs in NK medium (RPMI 
1640) and MEM-α medium at a ratio of 1:1 (50%:50%) corresponding to 
optimized conditions (data not shown). The IL-2 NK cells and hWJMSCs co-
culture were then placed in 5% CO2 at 37 °C, for 24 h. The resulted medium 
was preserved at -80 °C for the next assays to measure IFN- γ, TNF- α, perforin 
(Prf1), and granzyme B (GzmB) [25,28,29]. 
3.3 Cytotoxic activity of CM from Co-culture of hWJMSCs and 
IL-2 NK toward MCF-7 
MCF-7 cells were cultured at a density of 5 × 103 cells/well in DMEM medium 
added with 10% FBS and 1% Antibiotic-Antimycotic and then placed in 5% 
CO2 at 37 °C, for 24 h [23,26,27]. Moreover, the cells were treated with 
(hWJMSCs+NK)-CM, (hWJMSCs+IL-2 NK)-CM at concentrations of 30% or 
60% and incubated for 24 h. The viability of the cells was calculated using an 
MTS assay according to the manufacturer’s procedure (Section 2.2) [23,26]. 
3.4 Apoptosis Assay of CM from Co-culture of hWJMSCs and 
IL-2 NK toward MCF-7 using Flowcytometer 
MCF-7 at density 1x106 cells/disk were maintained in DMEM medium added 
with 10% FBS and 1% Antibiotic-Antimycotic and incubated at 37 °C, 5% CO2 
for 24 h. Moreover, the cells were treated using 50% CM of co-culture 
hWJMSCs and IL-2 induced NK (hWJMSC-CM, (hWJMSCs+NK)-CM, 
(hWJMSCs+IL12-NK)-CM)) and incubated for 24 h. Next, the cells were 
washed using phosphate buffered saline (PBS), harvested using 0.25% trypsin 
EDTA (Gibco, 25200072) and counted using a hemocytometer. Around 5 × 105 
to 1 × 106 counted cells were added with 500 μl of Annexin V binding buffer 
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(Miltenyi Biotec, 130-092-820), 5 μl of Anti-FITC (Miltenyi Biotec, 130-048-
701) and 5 μl of propidium iodide (Miltenyi Biotec, 130-093-233), and the cells 
were incubated in darkness at 4 °C. A MACSquant Analyzer 10 (Miltenyi 
Biotec) was used to analyze the apoptotic percentage of MCF-7 [26]. 
3.5 Real-time PCR Assay for the Apoptotic Induction of MCF-7 
Cell Lines by TNF-α, IFN-γ  
Recombinant human TNF-α (Biolegend 570106) and recombinant IFN-γ 
(Biolegend 570206) were used to determine the apoptosis induction ability 
toward MCF-7. MCF-7 cells at density 2 × 106/well were maintained in 500 μl 
of DMEM supplemented with 10% FBS, 1% Antibiotic-Antimycotic, TNF-α 
(175, 350 ng/ml), IFN-γ (175, 350 ng/ml) and incubated at 37 °C, 5% CO2 for 
24 h [30]. 
Total RNA from MCF-7 cells was isolated (AurumTM Total RNA Mini Kit, Bio-
Rad 732-6820) based on the manufacturer’s instructions. The total RNA yield 
was estimated spectrophotometrically at 260/280 nm (Table 1). The RNA 
quality was confirmed via electrophoresis, the RNA purity was verified and 
then the RNA was reverse-transcribed into cDNA (iScript cDNA Synthesis Kit, 
170- 8841; Bio-Rad). PCR amplification was carried out using a PikoRealTM 
Real-Time PCR System (Thermo Scientific Inc.). The qPCR conditions were 
pre-denaturation at 95 °C for 30 seconds, then 40 cycles of qPCR with 
denaturation for 5 seconds at 95 °C, annealing for 20 seconds at 58 °C, then 
elongation for 30 seconds at 72 °C using Sso7d-fusion Polymerase and 
EvaGreen Dye as detection system (SsoFastTM EvaGreen®Supermix, 172-
5201AP). The data analysis was calculated using Livak formula in Eq. (1): 
 ∆CTଵ → target gene expression (1) 
 ൌ CT௧௔௥௚௘௧௘ ௚௘௡௘ െ CT௛௢௨௦௘ି௞௘௘௣௜௡௚ ௚௘௡௘   
∆CTଶ → ∆CT௖௢௡௧௥௢௟  
ൌ CT௖௢௡௧௥௢௟ െ CT௛௢௨௦௘ି௞௘௘௣௜௡௚ ௚௘௡௘ 
∆∆CT → ∆CTଵ െ ∆CTଶ  
2 െ ∆∆CT → comparison of expression level 
As internal control, β-actin was included as the house-keeping gene. The 
primers used for RT-PCR are summarized as: β-actin (forward: 5'-TCT GGC 
ACC ACA CCT TCT ACA ATG-3', reverse: 5'-AGC ACA GCC TGG ATA 
GCA ACG-3'), p53 (forward: 5' AGA GTC TAT AGG CCC ACC CC 3', 
reverse: 5'-GCT CGA CGC TAG GAT CTG AC 3'), Bax (forward: 5'-TGC 
TTC AGG GTT TCA TCC AG 3', reverse: 5'-GGC GGC AAT CAT CCT CTG 
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3'), Bcl-2 (forward: 5'-GGT CAT GTG TGT GGA GAG CG -3', reverse: 5'-
GGT GCC GGT TCA GGT ACT CA-3') [31]. 
4 Results 
4.1 MSCs Markers and Differentiation 
Passage 4 (P4) hWJMSCs strongly expressed CD105, CD73 and CD90 (> 95%) 
and showed poor expression of CD34, CD45, CD14, CD19 and HLA-II (< 2%) 
[23]. The cells showed multipotent differentiation into adipocytes, 
chondrocytes, and osteocytes (data not shown). Therefore, hWJMSCs were 
confirmed based on the surface marker and differentiation capability [23,24,30]. 
4.2 Cytotoxic Activity of IL-2 hWJMSC-CMs toward BC Cells 
To determine the effect of CM from hWJMSCs treated with IL-2 at 
concentrations of 125 ng/ml and 250 ng/ml IL-2 hWJMSC-CM against BC cell 
proliferation, we evaluated the inhibition of IL-2 hWJMSC-CM on MCF-7 at 
two different concentrations of CM (30% and 60%) (Figure 1). 
 
Figure 1 The effect of IL-2 hWJMSC-CM on BC cell growth inhibition. 
The data are presented as a histogram of the treatments; the experiment was 
conducted in triplicate for each treatment. Significant differences between 
hWJMSC-CM (non-induced, induced by IL-2 125 ng/ml, induced by IL-2 250 
ng/ml) and non-hWJMSC-CM (100% MCF-7 medium), based on the Tukey 
HSD post hoc test (p < 0.05), in 30% and 60% of hWJMSC-CM are indicated 
by small letters (a,b) and capital letters (A,B), respectively. The # symbol 
indicates significant differences between the concentrations of 30% and 60% of 
hWJMSC-CM based on a Student’s t-test (p < 0.05). Figure 1 shows that 
hWJMSC-CM and IL-2 hWJMSC-CM inhibited cell proliferation and had 
anticancer activities against MCF-7 cells. The higher concentration (60%) of 
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hWJMSC-CM and IL-2 hWJMSC-CM increased the inhibition of BC cells 
(MCF-7) more compared to the lower concentration (30%) based on a Student’s 
t-test (p < 0.05).  
4.3 Effect of IL-2 hWJMSC-CM on NK cell inhibition 
IL-2 can activate and improve NK cells. Therefore we induced the hWJMSC-
CMs with IL-2 at different concentrations (125 and 250 ng/ml) to see the effect 
on inhibition of NK cell growth. This experiment was conducted in triplicate for 
each treatment. The results are shown in Figure 2. 
 
Figure 2 The effect of (IL-2 hWJMSCs)-CM on NK cell growth inhibition. 
The data are presented as histograms comparing the treatments. Significant 
differences between hWJMSC-CM (non-induced, induced by IL-2 125 ng/ml 
and by IL-2 250 ng/ml) and non-hWJMSC-CM (100% medium of NK cells), 
based on Tukey’s Honest Significant Difference test (p < 0.05), in 30% and 
60% of hWJMSC-CM are indicated by small letters (a,b) and capital letters 
(A,B,C), respectively. The # symbol represents significant differences between 
concentrations of 30% and 60% of CM-hWJMSCs based on a t-test (p < 0.05). 
Figure 2 shows that both hWJMSC-CM and (IL-2 hWJMSCs)-CM were toxic 
against NK cells. The (IL-2 hWJMSCs)-CM was significantly more toxic at 
higher concentration (60% CM) than at lower concentration (30% CM) of CM, 
with no significant differences between the different concentrations of IL-2. 
212 Wahyu Widowati, et al. 
 
4.4 Effect of IL-2 NK cells on the Level of TNF-α, IFN-γ, 
Perforin, and Granzyme in Co-cultured hWJMSCs and NK 
Cells  
Repairing and degrading damaged tissue is the function of NK cells, in addition 
to preventing pathogens [32]. A previous study suggested that MSCs have the 
ability to inhibit the proliferation and improve the functioning of immune cells, 
showing that MSCs influence the proliferation and cytolytic activities of NK 
cells [33-35] and the IFN-γ production [36]. NK cells were activated using IL-2 
(10 ng/ml) and non-induced-NK cells, which were co-cultured with hWJMSCs. 
The cells (hWJMSCs:NK cell ratio = 1:5) were assessed for the ability to 
secrete TNF-α, IFN-γ, perforin, and granzyme B. The effect of IL-2 inducer and 
NK cell number can be seen in Table 1. 
Table 1 Effect of IL-2 inducer and NK cell number on IFN-γ, TNF-α, perforin, 
and granzyme levels in co-cultured hWJMSCs and NK Cells. 
Co-culture hWJMSCs 
and (IL-2 NK) 
Concentrations of Effector Molecules Cytoplasmic Granules 
IFN-γ 
(pg/ml) 
TNF-α 
(pg/ml) 
Perforin 
(pg/ml) 
Granzyme B 
(pg/ml) 
hWJMSC-CM 0.94±0.19a 2.64±0.47a 0.00±0.00a 0.00±0.00a 
hWJMSC-CM+NK (1:5) 22.6±1.9b 8.58±0.07b 90±30b 16.3±3.2b 
hWJMSC-CM+IL-2 NK (1:5) 23.9±1.0b 28.1± 3.0c 180±10c 57.33±0.58c 
The data experiment was performed with 3 replications. The data of concentartions of IFN-γ, TNF-α, perforin, 
and granzyme (pg/ml) are presented as mean ± standard deviation. Different small letters in the same column 
(a,b for IFN-γ; a,b,c for TNF-α; a,b,c for perforin; a,b,c for granzyme) indicate significant differences between 
the treatments based on the Tukey HSD post-hoc test (p < 0.05).  
4.5 Effect CM from Co-Culture hWJMSCs and NK Cells 
towards Cytotoxic Effect of MCF-7 
Complex factors that can reduce cancer cell proliferation are secreted by MSCs 
[21-23]. The hWJMSC-CM can suppress the immunomodulatory system and 
NK cells and their cytotoxic effect. To increase the cytotoxic effect of hWJMSC 
and NK cells toward cancer cells, their activation is required. Cytokines such as 
interleukins can probably be used to directly boost the anticancer property of 
NK cells and indirectly that of hWJMSC-CM. hWJMSC-CM is known to 
exhibit anticancer activities because it contains microparticles that mediate 
therapeutic effects against cancer [18]. The MCF-7 cells were treated with 
(hWJMSC+NK)-CM, (hWJMSCs+IL-2 NK)-CM at concentrations of 30% or 
60% and incubated for 24 h (Table 2). 
Based on the cytotoxic data (Table 2), hWJMSC-CM inhibited MCF-7 
proliferation and its combination with NK and activated-NK cells increased 
cytotoxic activity of hWJMSC-CM toward MCF-7.  
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Table 2 Effect of CM from co-cultured hWJMSCs and IL-2 NK cells on 
MCF-7 proliferation. 
CM from co-cultured hWJMSCs 
and 
IL-2 activated NK Cells 
Proliferation Inhibition toward MCF-7 Cells (%) 
Concentration 30% 
of CM from co-cultured 
(hWJMSCs+ IL-2 NK) 
Concentration 60% 
of CM from co-cultured 
(hWJMSCs+ IL-2 NK) 
Non-CM (MCF-7 cells only) 0.00±6.6 a 0.00±6.6 a 
hWJMSC-CM 32.66±6.6 b 48.0±8.7 b 
hWJMSC-CM + NK (1:5) 42.1±3.6 bc 54.6±8.0 bc 
hWJMSC-CM + IL-2 NK (1:5) 61.5±1.3 c 68.3±3.8 c 
The data are presented as mean ± standard deviation. The proliferation inhibition was measured in triplicate 
for each sample. Different superscripts letters in the columns (a,b,bc,c) of 30% and 60% CM concentration of 
co-culture hWJMSCs and NK cells (number of hWJMSCs : NK = 1:5) indicate significant differences based 
on Tukey’s HSD test (P < 0.05). 
4.6 Effect of CM from Co-cultured hWJMSCs and IL-2 NK Cells 
toward MCF-7 Apoptosis 
Secretome components secreted by MSCs, such as chemokines, cytokines, and 
growth factors, are crucial to maintain the homeostasis and signal transduction 
with stromal cells (fibroblast, endothel cell, macrophage) [37]. These soluble 
factors in CM determine the fate of stem cells in in-vitro assays [38]. We 
measured the apoptosis ability of CM from co-cultured hWJMSC and IL-2 NK 
cells at a concentration of 50% in normal media towards MCF-7. The 
(hWJMSCs+IL-2 NK)-CM induced apoptosis of MCF-7 (Table 3, Figure 3).  
Table 3 Effect of CM from co-cultured hWJMSCs and IL-2 NK cells toward 
apoptosis of MCF-7. 
CM-(hWJMSCs + IL-2 NK) 
Early 
Apoptosis 
(%) 
Live  
(%) 
Necrosis 
(%) 
Dead (%) 
(Late 
Apoptosis) 
Non-CM (MCF-7 cells only) 4.51±0.78 a 87.1±1.6 c 6.74±0.29 b 1.65±0.78 a 
hWJMSC-CM 33.11±0.92 b 49.3±1.0 b 6.70±0.28 b 10.88±0.15 b 
(hWJMSCs+NK)-CM 34.7±1.9 b 53.2±3.8 b 4.87±0.22 a 7.3±1.7 b 
(hWJMSCs+IL-2 NK)-CM 36.5±2.7 b 42.47±0.65 a 5.01±0.87 a 15.9±1.7 c 
The data are presented as mean ± standard deviation. The number of early apoptosis, live, necrosis, and late 
apoptosis cells were measured in triplicate for each sample. Different superscript letters in the columns (a,b) 
of early apoptosis in CM of co-cultured hWJMSCs and IL-2 NK cells and different superscript letters (a,b,c) 
in the columns of living cells in CM of co-culture hWJMSCs and NK cells, different superscript letters (a,b) 
in the same column of necrosis in CM of co-culture hWJMSCs and NK cells, different superscript letters 
(a,b,c) in the same column of late apoptosis in CM of co-culture hWJMSCs and NK cells indicate significant 
differences based on a Tukey HSD post-hoc comparison (P < 0.05). 
Table 3 shows that CM from hWJMSCs, co-cultured hWJMSCs and NK cells, 
and from co-cultured hWJMSCs and NK cells activated by IL-2 (10 ng/mL) 
increased the number of early and late apoptotic cells, and reduced the number 
of live and necrosis MCF-7 cells. The CM from the co-cultured hWJMSCs and 
IL-2 activated NK cells was more active in inducing early apoptosis and killing 
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MCF-7 cells (late apoptosis) compared to the CM from co-culture with NK 
cells without activation, or from hWJMSC-CM alone. 
 
 
Figure 3  The effect of CM from co-cultured hWJMSCs and IL-2 activated NK 
cells on apoptosis of MCF-7 cells. 
The apoptosis percentage of BC cells treated with CM from co-culture of 
hWJMSCs and IL-2 activated NK cells was determined by flow cytometry.  
A: Control (MCF-7 cells untreated)  
B: MCF7 treated with hWJMSC-CM 
C: MCF7 treated with (hWJMSCs+NK)-CM, 
D: MCF7 treated with (hWJMSCs+IL12-NK)-CM  
Immunotherapy using activated-NK cells has been developed recently [6]. 
hWJMSC-CM induces apoptosis by upregulating Casp3 and Casp9 as the 
apoptotic genes and down-regulating the antiapoptotic genes in the human 
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U251 cell line [39]. The present research was performed to measure 
proapoptotic and antiapoptotic gene expression of Bax, p53, and Bcl-2 (Table 
4).  
Table 4 Effect of CM from Co-cultured hWJMSCs and IL-2 NK Cells toward 
Apoptotic Genes on BC Cells. 
The data are presented as mean ± standard deviation. The proapoptotic (Bax, p53) and antiapoptotic genes 
(Bcl-2) were measured in triplicate for each sample. Different superscript letters (a,ab,) in the same column in 
50% CM of co-culture hWJMSCs and IL-2 NK cells indicate significant differences based on a Tukey HSD 
post-hoc comparison (P < 0.05). 
Based on the data in Table 4, NK and activated-NK cells increased apoptotic 
gene expression (Bax and p53). CM-hWJMSCs and CM from co-culture 
hWJMSCs and NK cells did not significantly affect antiapoptotic gene 
expression (Bcl-2). 
5 Discussion 
CM contains many cytokines, growth factors, putative microvesicles, including 
(micro) RNA, IL-6, IL-8 [25], tumor growth factor-β1 (TGF-β1), monocyte 
chemoattractant protein-1 (MCP-1), Regulated upon Activation Normal T Cell 
Express Sequence (RANTES), collagen type I, fibronectin, secreted protein 
acidic and rich in cysteine (SPARC), and insulin-like growth factor binding 
protein-7 (IGFBP-7), which can be used as anticancer agents [36,40]. 
The ability of IL-2 to improve the anticancer activity of hWJMSC-CM both at 
CM concentrations of 30% and 60% against MCF-7 was not significantly 
different (Figure 1). However, the hWJMSC-CM could suppress MCF-7 
viability with an inhibition value of around 29-49%. A previous study showed 
that both CM from normoxic and hypoxic WJMSCs could inhibit cancer cell 
proliferation, including HeLa, SKOV3, PC3, HSC3, and HepG2 with IC50 
values of 51-74% [24], which is in line with our findings. Another research 
suggested that a 50% concentration of CM from hWJMSCs repressed breast 
adenocarcinoma (MDA-MB-231), ovarian carcinoma (TOV-112D), and 
osteosarcoma (MG-63) cells with 30-60% inhibition [40]. Even though the 
recombinant IL-2 was unable to improve the anticancer activity of hWJMSC-
CM, the cytotoxicity of hWJMSCs against cancer cells can be enhanced using 
engineering methods such as transfection and transduction. Thus, engineered 
Conditioned Medium 
(hWJMSCs + IL-2 NK)-CM Bax p53 Bcl-2 
Non-CM (MCF-7 cells only) 1.00±0.00 a 1.00±0.00 a 1.00±0.00  
hWJMSC-CM 1.36±0.36 ab 1.23±0.25 a 0.93±0.09  
(hWJMSCs+NK)-CM      1.52±0.17 b 1.47±0.15 ab 0.96±0.19  
(hWJMSCs+IL-2 NK)-CM 1.46±0.16 b 1.94±0.44 b 0.88±0.19  
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hWJMSCs expressing IL-2 can be used as anticancer agents, since hWJMSCs 
express IL-2 to regulate inflammation and possess anticancer activity via direct 
killing effects of tumors or positive modulating of the endogenous immune 
system [41,42]. 
Furthermore, the hWJMSC-CM and IL-2 hWJMSC-CM inhibited NK cell 
proliferation (Figure 2). The higher the CM concentration (60% CM), the more 
toxic the CM was against NK cells. The cytotoxic activity of hWJMSC-CM and 
(IL-2 hWJMSCs)-CM on NK cells was not significantly different, which 
indicates that IL-2 induction did not have a major effect on the cytotoxic 
activity of hWJMSC-CM. A previous study revealed that the hWJMSCs were 
toxic against NK cells, as MSCs produced PGE2 and TGF-β, which efficiently 
inhibited activation and suppressed the cytotoxicity effect of downstream 
resting NK cells toward cancer cells. [43]. Several studies have stated the 
interaction between NK cells and MSCs, revealing that NK cells killed MSCs 
and the MSCs strongly inhibited IL-2-induced NK cell proliferation and NK 
cell cytotoxicity, while CD244 and NKG2D were down-regulated under cell-to-
cell contact in the interaction between NK and MSCs in the presence of IL-2 or 
IL-15 or following stimulation by combinations of IL-12/IL-15 and IL-12/1L-
18 [33,44-46]. Also, the function of NK cells is impaired by the combination of 
human adult stem cells (hASCs) and bone marrow mesenchymal stem cells 
(hBM-MSCs) [47].  
There are four mechanisms in activated NK cells to kill targeted cancer cells: 
releasing cytoplasmic granules (perforin, granzyme), death receptor-induced 
apoptosis (FasL, TRAIL, TNF-α), effector molecule production (IFN-γ), and 
antibody-dependent cellular cytotoxicity (ADCC), a result of Fc-γ receptor 
(FcγR) mediated interaction with NK cells [16,48]. The activation of granzyme 
and perforin release from NK cells is triggered by binding of FcγR to the Fc 
domain, causing target tumor cell lysis and Fc-dependent tumor cell 
phagocytosis [48,49]. NK cells contribute to the tumor death process by 
monoclonal antibody (mAb) therapy by directing ADCC through Fcg RIIIA 
(CD16) [50]. 
The hWJMSC-CM has potential anti-cancer activity toward various cancer 
cells, such as HeLa, SKOV3, HepG2, PC3, HSC3, A549, HT29, MCF-7 [23, 
39]. MSCs inhibit immune system cell proliferation and functions such as NK 
cell cytotoxicity by suppressing TNF-α and IFN-γ secretion [33-35,51]. 
However, this research revealed that IL-2 could improve cytotoxicity of NK 
cells, co-culture IL-2 NK and hWJMSCs by increasing TNF-α, IFN-γ, GzmB 
and Prf1 secretion (Table 1). ILs (IL-2, IL-12, IL-15, IL-18) and IFNs control 
NK cell cytotoxic activities [52]. This finding is relevant to another study, 
which suggested that co-cultured NK cells and human adipocyte stem cells 
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(hASCs) secrete 40±32.5 pg/ml IFN-γ but co-culture of uninduced NK cells and 
hASCs does not secrete IFN-γ [47], which is relevant to hWJMSC-CM’s 
cytotoxic effect of killing cancer cells using the apoptosis pathway (Tables 3 & 
4).  
The production of TNF-α, IFN-γ, Prf1, GzmB increased when the ratio of NK 
cells was high (Table 1), meaning that the cytotoxic effect of NK cells also 
increased. This result is relevant to a previous study, where there was 
interaction between MSCs with both the innate and the adaptive immune 
system, leading to the activation of some effector functions [53]. The 
phenotype, cytokine secretion, and proliferation of NK cells were suppressed at 
lower NK-to-MSCs ratios, which affected the innate immune responses and 
regulation of adaptive immunity [34]. Moreover, the secretion of IFN-γ was 
improved when co-cultured hASCs, hBM-MSCs and NK cells were at a ratio of 
1:1 for 72 h, as well as co-cultured hASCs and IL-2-expanded NK cells [46,54]. 
The co-cultured NK cells and AML (K562) cancer cells secreted the highest 
amount of IFN-γ compared to the co-cultures of NK+hASCs and NK+hBM-
MSCs, while the lowest amount of IFN-γ was produced by NK control [46]. 
The MSCs inhibit the activated NK cells and effector and induction functions 
such as cytotoxic activity and cytokine production [46]. This is in line with the 
present research results (Figure 2).  
Prf1 mediates cytotoxicity with direct killing by NK cells and indirect killing by 
secreting death-inducing ligands [55]. Cell growth inhibition and cell death, 
apoptosis, chromosome condensation and DNA fragmentation, increased Casp-
3 activity, and the release of apoptosis-inducing factor (AIF) and cytochrome c 
from the mitochondria toward cancer cells (HepG2, SK-BR-3, and HeLa) are 
activated by Prf1 secretion [56]. 
The surface of the target cells is bounded by Gzm in the concentration-
dependent and saturable manners and transported into the cells via endocytosis 
[57]. The internalization of GzmB into target cells is determined by Prf1 [57]. 
Apoptosis through the intrinsic mitochondrial pathway is mainly induced by 
GzmB, either by cleaving Bid or activating Bim, leading to Bak/Bax activation 
and subsequent signal transduction of Casp-3 activation [58]. GzmB secreted in 
CM of co-cultured hWJMSCs and NK cells activated apoptosis (Table 1) and 
also induced the expression of Bax genes (Table 4). Activation of p53 tumor 
suppressor genes as one of the apoptosis pathways is induced by GzmB to kill 
cancer cells [59]. Apoptosis in human carcinoma cell lines such as HCT116-3 
[60] and MCF-7 [61] is induced using TNF-α, including PKR activation in 
U937 [62]. 
218 Wahyu Widowati, et al. 
 
IFNγ modulates the pro-apoptotic genes but not pro-necrotic genes in HT-29 as 
a cell death program through sensitizing the cells [63]. Treatment of IFNγ on a 
human conjunctival cell line resulted in overexpression of Bax, whereas Bcl-2 
and p53 protein levels were not modified. Protecting (Bcl-2, Bcl-Xl) or 
sensitizing (Bax, bak, bad) causing the cell to undergo apoptosis is controlled 
by the Bcl-2 protein family [64]. IFNγ-inducible protein 10 (IP10) upregulates 
p53 and induces Bax expression on HeLa cells [65]. IFN-γ enhances apoptosis 
by decreasing the mitochodrial membrane potential, upregulating p53 and Bax, 
down-regulating Bcl-xL, and improving caspase-3 activity [66]. 
In conclusion, the IL-2 hWJMSC-CM and hWJMSC-CM had anticancer 
activities against BC cells, where higher CM concentrations increased the 
inhibition potency. The IL-2 hWJMSC-CM and hWJMSC-CM had toxic 
activity against NK cells, where higher CM concentrations increased the 
inhibition potency. A large number of NK and IL-2 inducer cells increased the 
secretion of TNF-α, IFN-γ, Prf1 and GzmB, which play a role as potent 
anticancer agents. (hWJMSCs+IL-2 NK)-CM was toxic against BC cells, where 
a higher concentration of (hWJMSCs+IL-2 NK)-CM increased cytotoxic 
activities. The (hWJMSCs+IL-2 NK)-CM induced apoptosis in BC cells 
through increasing apoptotic gene expression (Bax, p53). Further research and 
preclinical and clinical studies should be pursued prior to therapy application. 
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